Galectin Therapeutics (Nasdaq:GALT) reached up 82.80% in morning trading to $3.2355 with 900K shares traded. Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, key mediators of biologic function. They are leveraging extensive scientific and development expertise as well as established relationships with external sources to achieve cost effective and efficient development. They are pursuing a clear development pathway to clinical enhancement and commercialization for their lead compounds in liver fibrosis and cancer. Galectin Therapeutics (GALT) today announced that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Number 8,236,780 “Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies”.
InterCore Energy, Inc. (OTCBB: ICOR) reached up 34.33% in morning trading to $.09 with 700K shares traded. InterCore Energy, Inc. is a public company that, in addition to managing its own operating entities, plans to participate in emerging companies in the energy sector that are run by exceptionally talented entrepreneurs and operating executives who are dedicated to creating positive change in our world. InterCore functions as an owner, product developer, and investor focused primarily on providing equity, acquisition debt, or bridge financing to emerging high-growth companies and entrepreneurs in the area of clean energy. InterCore Energy, Inc. (OTCBB: ICOR) announced that on Friday, July 20, 2012, its Board of Directors adopted a resolution granting warrants to the Company's senior management team. The structure of the warrant packages is consistent with one of the basic operating principles of ICOR: that management's rewards would be linked to ICOR's financial performance. The intention has always been that management would have performance-linked incentives that places the management team and the Company's investors on the same side of the table.
IDO Security Inc. (OTCBB:IDOI) reached up 12.20% in morning trading to $.69 with 2M shares traded. Headquartered in New York with a subsidiary in Israel, IDO Security designs, develops and markets the patented MagShoe™ shoe scanning device (SSD), filling a critical void in today's detectors by extending screening to the lower body and feet. MagShoe™'s "shoes-on" design maximizes security, thoroughness and accuracy while eliminating the need to remove shoes for increased convenience and safety; neither invasive nor harmful to the body as some of the other screening devices currently used in the marketplace. Ideal for security and loss prevention at virtually any facility, MagShoe™ is currently in use worldwide at international airports, cruise lines, government agencies, correctional facilities, mints and more. IDO Security Inc. (IDOI) Friday announced that the Company is demonstrating the MagShoe at an Illinois prison facility as a pilot program for Illinois officials to confirm the effectiveness of the MagShoe to combat the penetration of cellular phones, electronic devices and weapons that have been a known concern in correctional facilities across the U.S.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
